Your browser version may not work well with NCBI's Web applications. More information here...
1: Am J Ophthalmol. 1998 Oct;126(4):602-4.Click here to read Links

Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.

Ayyala RS, Cruz DA, Margo CE, Harman LE, Pautler SE, Misch DM, Mines JA, Richards DW.

Department of Ophthalmology, University of South Florida, Tampa, USA. rsayyala@hotmail.com

PURPOSE: To describe four patients who developed cystoid macular edema shortly after onset of treatment with latanoprost. METHOD: Retrospective review of medical records of patients with open-angle glaucoma who developed cystoid macular edema shortly after starting latanoprost. RESULTS: The use of topical latanoprost was temporally related to the development of cystoid macular edema in four patients (six eyes; two aphakic eyes and four pseudophakic eyes). Cystoid macular edema resolved in all patients after latanoprost was discontinued. CONCLUSIONS: Cystoid macular edema is a potential complication of latanoprost therapy. Further observations are needed to determine if the risk of cystoid macular edema is limited to or greatest in patients who are pseudophakic or aphakic.

PMID: 9780112 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • How to Use Eyedrops

    Wash your hands thoroughly with soap and water. Check the dropper tip to make sure that it is not chipped or cracked. Avoid touching the dropper tip against your eye or anything else—eyedrops and dropper must be k...

  • Latanoprost (Xalatan® )

    Latanoprost is a topical eye medication used to reduce pressure inside the eye. It is used to treat eye conditions, including glaucoma and ocular hypertension, in which increased pressure can lead to a gradual loss of vi...

  • Source: AHFS Consumer Medication Information